For Q4 2024, the John Hancock U.S. Global Leaders Growth fund posted a small gain that trailed the return of its benchmark ...

For Q4 2024, the John Hancock U.S. Growth Fund underperformed the benchmark Russell 1000 Growth Index. Click here to read the ...

Gorman-Rupp has grown its operations. Read why I require confirmation of growth and/or pullback in GRC share price before ...

Tesla's deferred FSD revenue and limited Robotaxi rollout show promise, but currently lack meaningful financial impact. Read ...

TransMedics' NOP advances organ transplantation with improved outcomes & cost reductions. See why I rate TMDX stock a strong ...

Rapport Therapeutics focuses on developing specific small molecule therapies for CNS diseases. Check out my recommendation ...

Phantom Liberty DLC exceeded our sales expectations, solidifying Cyberpunk 2077 IP's strength. See why I upgrade the stock ...

DiDi Global (DIDIY) dominates China's shared mobility market with strong profitability growth and competitive advantages. See ...

The John Hancock Mortgage-Backed Securities ETF outperformed its benchmark, the Bloomberg U.S. MBS Index for Q4 2024. Click ...

The John Hancock International Growth Fund outperformed the MSCI All Country World ex-USA Growth Index for Q4 2024. Click ...

The John Hancock Seaport Long/Short Fund didn’t keep pace with its benchmark, the MSCI World Index for Q4 2024. Click here to ...

NANO Nuclear's MMRs are more appropriate for its market niche than any other competitor. Read why I rate NNE stock a ...